Kearns Sayre syndrome: An unusual form of mitochondrial diabetes

Diabetes and Metabolism

Volumn 32, Issue 2, 2006, Pages 182-186

  Laloi Michelin, M ^a   Virally, M ^a   Jardel, C ^b   Meas, T ^a   Ingster Moati, I ^a   Lombes A ^b   Massin, P ^a   Chabriat, H ^a   Tielmans, A ^a   Mikol, J ^a   Guillausseau, P J ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Kearns Sayre syndrome; Mitochondrial diabetes; Mitochondrial DNA; Monogenic diabetes

Indexed keywords

INSULIN; METFORMIN; MITOCHONDRIAL DNA; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DIABETES MELLITUS; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DETERMINATION; EXTERNAL OPHTHALMOPLEGIA; FEMALE; HUMAN; HUMAN TISSUE; KEARNS SAYRE SYNDROME; LABORATORY TEST; PTOSIS;

EID: 33645973264     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70267-7     Document Type: Article

References (19)

1. Kearns TP, Sayre GP. Retinitis pigmentosa, external ophtalmoplegia and complete heart block. Arch Ophthalmology 1958;60:280-9
2. Moraes CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989;320:1293-9
3. Marin-Garcia J, Goldenthal MJ, Flores-Sarnat L, Sarnat HB. Severe mitochondrial cytopathy with complete A-V block, PEO, and mtDNA deletions. Pediatr Neurol 2002;2:213-6
4. Hammans SR, Sweeney MG, Hanna MG, Brockington M, Morgan-Hughes JA, Harding AE. The mitochondrial DNA transfer RNALeu (UUR) A→G (3243) mutation. A clinical and genetic study. Brain 1995;118:721-34
5. Poulton J, O'Rahilly S, Morten KJ, Clarck A. Mitochondrial DNA, diabetes and pancreatic pathology in Kearns-Sayre syndrom. Diabetologia 1995;38:868-871
6. Ashcroft E, Ashcroft S. Mechanism of insulin secretion. In: Ashcroft E, Ashcroft S (eds). Insulin: molecular biology to pathology.1992. Oxford University Press Oxford: 97-150
7. Kishimoto M, Hashiramoto M, Araki S, Ishida Y, Kazumi T, Kanda F. Diabetes mellitus carrying a mutation in the mitochondrial t RNA gene. Diabetologia 1995;38:193-200
8. Oka Y, Katagiri H, Yakazi Y, Murase Y, Kobayashi T. Mitochondrial gene mutation in islet antibody positive patients who were initially non insulin dependent diabetics. Lancet 1993;342:527-8
9. Rubi-Palomares I, Martinez-Leon MI, Vera-Medialdea R, Delgado-Marques MP, Lopez-Ruiz P. Kearns-Sayre syndrome: pediatric neuroradiologic findings in computed tomography and magnetic resonance imaging. An Esp Pediatr 2002;56:180-4
10. Harvey JN, Barnett D. Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol (Oxf) 1992;37:97-103
11. Boles RG, Roe T, Senadheera D, Mahnovski V, Wong Lf. Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease. Eur J Pediatr 1998;157:643-7
12. De Block CE, De Leeuw IH, Maassen JA, Ballaux D, Martin JJ. A novel 7301-bp deletion in mitochondrial DNA in a patient with Kearns-Sayre syndrome, diabetes mellitus, and primary amenorrhoea. Exp Clin Endocrinol Diabetes 2004;112:80-3
13. Robertson WC, Viseskul C, Lee YE, Lloyd RV. Basal ganglia calcification in Kearns Sayre Syndrome. Arch Neurol 1979;36:711-3
14. Barragan-Campos HM, Vallée JN, Lo D, et al. Brain Magnetic Resonance imaging findings in patients with mitochondrial cytopathies. Arch Neurol 2005;62:737-42
15. Shanske S, Moraes CT, Lombes A, et al. Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology 1990;40:24-8
16. Moraes CT, Ricci E, Petruzella V, Shanskse S, DiMauro S, Schon EA. Molecular analysis of the muscle pathology associated with mitochondrial DNA deletions. Nat Genet 1992;1:359-67
17. Reichmann H, Degoul F, Gold R, et al. Histological, enzymatic and mitochondrial DNA studies in patients with Kearns-Sayre syndrome and chronic progressive external ophthalmoplegia. Eur Neurol 1991;31:108-13
18. Schnitzler ER, Robertson WC Jr. Familial Kearns-Sayre syndrome. Neurology 1979;29:1172-4
19. Choi C, Sunwoo IN, Kim HS, Kim DI. Transient improvement of pyruvate metabolism after coenzyme Q therapy in Kearns-Sayre syndrome: MRS study. Yonsei Med J 2000;41:676-9